Hassan R - Search Results

1

Thomas A, Maltzman J, Hassan R. Thomas A, et al. Among authors: hassan r. Lung Cancer. 2013 Apr;80(1):15-8. doi: 10.1016/j.lungcan.2012.12.021. Epub 2013 Jan 26. Lung Cancer. 2013. PMID: 23357463 Free PMC article. Review.

2

Mesothelin expression in human lung cancer.

Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I. Ho M, et al. Among authors: hassan r. Clin Cancer Res. 2007 Mar 1;13(5):1571-5. doi: 10.1158/1078-0432.CCR-06-2161. Clin Cancer Res. 2007. PMID: 17332303

3

Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.

Hassan R, Schweizer C, Lu KF, Schuler B, Remaley AT, Weil SC, Pastan I. Hassan R, et al. Lung Cancer. 2010 Jun;68(3):455-9. doi: 10.1016/j.lungcan.2009.07.016. Epub 2009 Sep 9. Lung Cancer. 2010. PMID: 19744744 Free PMC article. Clinical Trial.

4

Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.

Hassan R, Cohen SJ, Phillips M, Pastan I, Sharon E, Kelly RJ, Schweizer C, Weil S, Laheru D. Hassan R, et al. Clin Cancer Res. 2010 Dec 15;16(24):6132-8. doi: 10.1158/1078-0432.CCR-10-2275. Epub 2010 Oct 29. Clin Cancer Res. 2010. PMID: 21037025 Free PMC article. Clinical Trial.

5

Chemotherapy and targeted therapies for unresectable malignant mesothelioma.

Kelly RJ, Sharon E, Hassan R. Kelly RJ, et al. Among authors: hassan r. Lung Cancer. 2011 Sep;73(3):256-63. doi: 10.1016/j.lungcan.2011.04.014. Epub 2011 May 28. Lung Cancer. 2011. PMID: 21620512 Free PMC article. Review.

6

Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell.

Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R. Kalra N, et al. Among authors: hassan r. Int J Cancer. 2012 Nov 1;131(9):2143-52. doi: 10.1002/ijc.27471. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22323052 Free PMC article.

7

Mesothelin-targeted agents in clinical trials and in preclinical development.

Kelly RJ, Sharon E, Pastan I, Hassan R. Kelly RJ, et al. Among authors: hassan r. Mol Cancer Ther. 2012 Mar;11(3):517-25. doi: 10.1158/1535-7163.MCT-11-0454. Epub 2012 Feb 17. Mol Cancer Ther. 2012. PMID: 22351743 Free PMC article. Review.

8

Immunotherapies for non-small-cell lung cancer and mesothelioma.

Thomas A, Hassan R. Thomas A, et al. Among authors: hassan r. Lancet Oncol. 2012 Jul;13(7):e301-10. doi: 10.1016/S1470-2045(12)70126-2. Epub 2012 Jun 28. Lancet Oncol. 2012. PMID: 22748269 Free PMC article. Review.

9

New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Mossman BT, Shukla A, Heintz NH, Verschraegen CF, Thomas A, Hassan R. Mossman BT, et al. Among authors: hassan r. Am J Pathol. 2013 Apr;182(4):1065-77. doi: 10.1016/j.ajpath.2012.12.028. Epub 2013 Feb 8. Am J Pathol. 2013. PMID: 23395095 Free PMC article. Review.

10

Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.

Hassan R, Miller AC, Sharon E, Thomas A, Reynolds JC, Ling A, Kreitman RJ, Miettinen MM, Steinberg SM, Fowler DH, Pastan I. Hassan R, et al. Sci Transl Med. 2013 Oct 23;5(208):208ra147. doi: 10.1126/scitranslmed.3006941. Sci Transl Med. 2013. PMID: 24154601 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters